Profiles

Kehinde Obamiro

UTAS Home Dr Kehinde Obamiro
Kehinde Obamiro

Kehinde Obamiro

Lecturer in Rural Health
Centre for Rural Health

E , Newnham Campus

+61 3 6324 3830 (phone)

kehinde.obamiro@utas.edu.au

Kehinde has a background in pharmacy and has undertaken training in public health. He is a lecturer at the Centre for Rural Health and has led several population wide surveys related to cardiovascular disease and bowel cancer. His main research interest includes promoting an evidence-based rural health agenda, public health (epidemiology, biostatistics and disease surveillance) and clinical pharmacy.

Rural Pharmacy Liaison Officer Program

Kehinde also functions as a rural pharmacy liaison officer to support students on placement and improve collaboration between pharmacists, pharmacy students and the university community, and to promote professional development and networking opportunities as required.

Biography

Kehinde completed a Bachelor of Pharmacy at the Ahmadu Bello University in 2008 and a Masters in Clinical Pharmacy at the University of Lagos, Nigeria in 2013. In late 2014, he moved to the University of Tasmania to undertake his PhD, which focused on assessment of oral anticoagulation knowledge and adherence in patients with atrial fibrillation. He completed his PhD in 2018 and took up a Lecturer appointment in the same year.

Career summary

Qualifications

  • PhD, University of Tasmania, Australia, 2018
  • Graduate Certificate in Research, University of Tasmania, Australia, 2015
  • Masters in Clinical Pharmacy University of Lagos, Nigeria, 2013
  • Bachelor of Pharmacy, Ahmadu Bello University, Nigeria, 2008

Languages (other than English)

Yoruba and Hausa

Teaching

Teaching expertise

Kehinde has tutored statistics to undergraduate students and provided supplementary tuition as a Riawunna tutor to students of Aboriginal and Torres Island descent. Kehinde is currently in a research intensive position but contributes to teaching at the School of Health Sciences when required.

View more on Dr Kehinde Obamiro in WARP

Fields of Research

  • Clinical Pharmacy and Pharmacy Practice (111503)
  • Clinical Pharmacology and Therapeutics (111502)
  • Health Promotion (111712)
  • Health and Community Services (111708)
  • Aboriginal and Torres Strait Islander Health (111701)
  • Public Health and Health Services (111799)
  • Health, Clinical and Counselling Psychology (170106)

Research Objectives

  • Health (929999)
  • Cardiovascular System and Diseases (920103)
  • Health Education and Promotion (920205)
  • Expanding Knowledge in the Medical and Health Sciences (970111)
  • Behaviour and Health (920401)
  • Carer Health (920202)
  • Allied Health Therapies (excl. Mental Health Services) (920201)
  • Rural Health (920506)
  • Public Health (excl. Specific Population Health) (920499)

Publications

Total publications

14

Journal Article

(9 outputs)
YearCitationAltmetrics
2020Obamiro K, West S, Lee S, 'Like, comment, tag, share: Facebook interactions in health research', International Journal of Medical Informatics, 137 Article 104097. ISSN 1386-5056 (2020) [Refereed Article]

DOI: 10.1016/j.ijmedinf.2020.104097 [eCite] [Details]

Co-authors: West S; Lee S

Tweet

2018Magon A, Arrigoni C, Roveda T, Grimoldi P, Dellafiore F, et al., 'Anticoagulation Knowledge Tool (AKT): further evidence of validity in the Italian population', PLoS One, 13, (8) Article e0201476. ISSN 1932-6203 (2018) [Refereed Article]

DOI: 10.1371/journal.pone.0201476 [eCite] [Details]

Citations: Scopus - 2Web of Science - 3

Tweet

2018Obamiro K, Lee K, 'Information overload in patients with atrial fibrillation: can the cancer information overload (CIO) scale be used?', Patient Education and Counseling, 102, (3) pp. 550-554. ISSN 0738-3991 (2018) [Refereed Article]

DOI: 10.1016/j.pec.2018.10.005 [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Lee K

Tweet

2018Obamiro KO, Chalmers L, Lee K, Bereznicki BJ, Bereznicki LR, 'Adherence to oral anticoagulants in atrial fibrillation: an Australian survey', Journal of Cardiovascular Pharmacology and Therapeutics, 23, (4) pp. 337-343. ISSN 1074-2484 (2018) [Refereed Article]

DOI: 10.1177/1074248418770201 [eCite] [Details]

Citations: Scopus - 10Web of Science - 8

Co-authors: Chalmers L; Lee K; Bereznicki BJ; Bereznicki LR

Tweet

2018Obamiro KO, Chalmers L, Lee K, Bereznicki BJ, Bereznicki LRE, 'Anticoagulation knowledge in patients with atrial fibrillation: an Australian survey', International journal of clinical practice, 72, (3) Article e13072. ISSN 1368-5031 (2018) [Refereed Article]

DOI: 10.1111/ijcp.13072 [eCite] [Details]

Citations: Scopus - 7Web of Science - 8

Co-authors: Chalmers L; Lee K; Bereznicki BJ; Bereznicki LRE

Tweet

2017Rolls CA, Obamiro KO, Chalmers L, Bereznicki LRE, 'The relationship between knowledge, health literacy and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation', Cardiovascular therapeutics, 35, (6) Article e12304. ISSN 1755-5914 (2017) [Refereed Article]

DOI: 10.1111/1755-5922.12304 [eCite] [Details]

Citations: Scopus - 13Web of Science - 11

Co-authors: Chalmers L; Bereznicki LRE

Tweet

2016Obamiro KO, Chalmers L, Bereznicki LRE, 'A summary of the literature evaluating adherence and persistence with oral anticoagulants in atrial fibrillation', American Journal of Cardiovascular Drugs, 16, (5) pp. 349-363. ISSN 1175-3277 (2016) [Refereed Article]

DOI: 10.1007/s40256-016-0171-6 [eCite] [Details]

Citations: Scopus - 29Web of Science - 23

Co-authors: Chalmers L; Bereznicki LRE

Tweet

2016Obamiro KO, Chalmers L, Bereznicki LRE, 'Development and validation of an oral anticoagulation knowledge tool (AKT)', PloS one, 11, (6) Article e0158071. ISSN 1932-6203 (2016) [Refereed Article]

DOI: 10.1371/journal.pone.0158071 [eCite] [Details]

Citations: Scopus - 16Web of Science - 14

Co-authors: Chalmers L; Bereznicki LRE

Tweet

2016Obamiro KO, Kunle R, 'Vorapaxar: A novel agent to be considered in the secondary prevention of myocardial infarction', Journal of pharmacy & bioallied sciences, 8, (2) pp. 98-105. ISSN 0976-4879 (2016) [Refereed Article]

DOI: 10.4103/0975-7406.171690 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Tweet

Conference Publication

(5 outputs)
YearCitationAltmetrics
2019Obamiro KO, Cooper A, Barnett T, 'Recruitment and retention of pharmacists in rural and remote areas of Australia: a scoping review', Bookof poster abstracts of the annual conference of the Australasian Pharmaceutical Science Association, 1-4 December 2019, Melbourne, pp. 1-55. (2019) [Conference Extract]

[eCite] [Details]

Co-authors: Cooper A; Barnett T

Tweet

2017Obamiro KO, Chalmers L, Lee K, Bereznicki BJ, Bereznicki LR, 'Gaps in anticoagulation knowledge in patients with atrial fibrillation', ASCEPT ASM / 2017 Annual Scientific Meeting, 5-8 December 2017, Brisbane, Australia (2017) [Conference Extract]

[eCite] [Details]

Co-authors: Chalmers L; Lee K; Bereznicki BJ; Bereznicki LR

2016Obamiro KO, Rolls CA, Chalmers L, Bereznicki LRE, 'The relationship between anticoagulation knowledge, health literacy and medication adherence in patients with atrial fibrillation', APSA Annual Conference 2016, 2-5 December 2016, Sydney, Australia (2016) [Conference Extract]

[eCite] [Details]

Co-authors: Chalmers L; Bereznicki LRE

2015Obamiro KO, Chalmers L, Bereznicki LRE, 'Development and validation of an oral anticoagulant knowledge instrument', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Chalmers L; Bereznicki LRE

2015Obamiro KO, Chalmers L, Bereznicki LRE, 'Development and validation of an oral anticoagulant knowledge instrument', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Chalmers L; Bereznicki LRE

Grants & Funding

Funding Summary

Number of grants

2

Total funding

$19,868

Projects

Bowel Cancer Awareness in Tasmania: a pilot study (2019)$10,000
Description
Bowel cancer is the second most common cause of cancer in Australia after prostate cancer, and the second most common cause of cancer deaths after lung cancer. This is despite the fact that bowel cancer is one of the most preventable cancers through lifestyle risk factor modification and early detection. Levels of population knowledge and awareness around bowel cancer prevention, screening and symptoms is currently unknown. This study seeks to: determine bowel cancer knowledge and awareness in the overall Australian population; identify knowledge gaps in specific regions, and; identify determinants of poor bowel cancer knowledge.This will be achieved through a national survey using the validated Bowel Cancer Awareness Measures tool developed by the University College London and Cancer Research UK.Currently in Australia, there is limited research focusing on the awareness of risk factors, screening, and symptoms of bowel cancer. This study is the first to focus on gathering large population-level and spatial data across Australia concerning bowel cancer awareness. The findings from this research will be useful in identifying sub-groups of the population with insufficient awareness regarding bowel cancer risk factors, screening programme and warning signs, that will benefit from tailored educational intervention.
Funding
Cancer Council of Tasmania ($10,000)
Scheme
Grant-Small
Administered By
University of Tasmania
Research Team
Obamiro KO; Lee SM
Year
2019
Factors associated with bowel cancer survival in Tasmania: A data linkage study (2018)$9,868
Funding
University of Tasmania ($9,868)
Scheme
Grant - DKD Research Theme
Administered By
University of Tasmania
Research Team
Lee SM; Radford JC; Versace V; Obamiro KO
Year
2018